Diseases, Conditions, Syndromes

A new understanding of how the immune system deals with malaria

By analyzing samples from patients who have been treated for malaria in Sweden, researchers at Karolinska Institutet can now describe how the immune system acts to protect the body after a malaria infection. The results, ...

Diseases, Conditions, Syndromes

Hunting the 'perfect protein' for malaria mRNA vaccine

After the success of mRNA vaccines against COVID-19, scientists are cautiously optimistic that the same technology can be used to tackle other widespread diseases such as malaria. The technology is promising, say vaccine ...

Diseases, Conditions, Syndromes

WHO mass-testing three potential COVID-19 treatments

The World Health Organization on Wednesday announced major international trials of three drugs to find out whether they improve the condition of hospitalised COVID-19 patients.

Diseases, Conditions, Syndromes

Blocking how the malaria parasite suppresses the immune response

The parasites that cause severe malaria are well-known for the sinister ways they infect humans, but new research may lead to drugs that could block one of their most reliable weapons: interference with the immune response.

Diseases, Conditions, Syndromes

Diabetes and obesity risk factors for severe malaria

Infectious diseases doctor Katja Wyss's thesis is the product of many years' research on malaria in Sweden. With clinical data from almost 3,000 diagnosed cases over a twenty-year time span, Katja Wyss at Karolinska Institutet's ...

Medications

FDA approves IV artesunate for severe malaria

Intravenous (IV) artesunate received approval from the U.S. Food and Drug Administration to treat adults and children with severe malaria, the agency announced Tuesday.

page 1 from 5